This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Attendees can join with their peers and participate in sessions on structural heartdisease, congenitalheartdisease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronaryarterydisease, vascular heartdisease, debates and games and early career topics.
The 2024 Latin American Cardiovascular Conference, held in Buenos Aires, brought together leading experts from across the Americas and Europe and focused on key areas of cardiovascular medicine, such as coronaryarterydisease, congenitalheartdisease, atrial fibrillation, and heart failure.
This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.
The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronaryarterydisease and cardio-oncology issues in seconds.
In congenitalheartdiseases, SDoHs can affect major outcomes, as well. In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.
In preparation for the ABIM Cardiovascular Disease exam, check out the BoardVitals Cardiology Board Review Question Bank and we’ll make sure you’re well versed in the following 13 areas covered on the exam: Multiple-Choice Component Arrhythmias 15% CoronaryArteryDisease 23% Heart Failure and Cardiomyopathy 17% Valvular Disease 15% Pericardial (..)
This 3-day event will bring together a world-class, international faculty to explore the latest developments and best practices in coronaryarterydisease, congenitalheartdisease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content